FIELD: medicine.
SUBSTANCE: invention refers to the compound 3-{[5-(azetidine-1-ylcarbonyl)pyrazine-2-yl] oxy}-5-{[(1S)-1-methyl-2-(methyloxy)ethyl]oxy}-N-(5-methylpyrazine-5-yl)benzamide or to its pharmaceutically acceptable salt. Also, it refers to a pharmaceutical composition for treating insulin-independent diabetes or obesity containing said compound.
EFFECT: there is produced and described a new compound which can be effective in treating insulin-independent diabetes and obesity.
5 cl, 64 ex
| Title | Year | Author | Number |
|---|---|---|---|
| HETEROARYLBENZAMYL DERIVATIVES FOR APPLICATION AS GLUCOKINASE (GLK) ACTIVATORS IN TREATMENT OF DIABETES | 2005 |
|
RU2403246C2 |
| BENZAMIDE DERIVATIVES AND APPLICATION AS GLUCOKINASE ACTIVATION AGENTS | 2005 |
|
RU2392275C2 |
| BENZOYLAMINOHETEROCYCLYL COUMPOUNDS AS GLUCOKINASE (GLK) ACTIVATORS | 2007 |
|
RU2440992C2 |
| NOVEL PHENYL PYRROLE DERIVATIVE | 2009 |
|
RU2470917C2 |
| DERIVATIVES OF PHENYLALCAN ACID AND PHENYLOXYALCAN ACID, THEIR APPLICATION AND PHARMACEUTICAL COMPOSTION THAT CONTAINS THEM | 2003 |
|
RU2323929C2 |
| (3-CYCLOALKYL-2, 3, 4, 5 - TETRAHYDRO-1H-BENZO [d] AZEPIN-7-YLOXY) DERIVATIVES, USE THEREOF FOR INHIBITING H3 RECEPTORS, PHARMACEUTICAL COMPOSITION AND PREPARATION METHOD | 2003 |
|
RU2388752C2 |
| INHIBITORS OF LYSINE-SPECIFIC GINGIPAIN | 2015 |
|
RU2728785C2 |
| COMPOUNDS AND COMPOSITIONS AS GPR119 ACTIVITY MODULATORS | 2008 |
|
RU2443699C2 |
| IMIDAZOPYRIDINE OR IMIDAZOPYRIMIDINE DERIVATIVES AS PHOSPHODIESTERASE 10A INHIBITORS | 2010 |
|
RU2502737C2 |
| NEW AZETIDINE COMPOUNDS | 2004 |
|
RU2356888C2 |
